Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 7/20 | 0.74 |
| ▸ | TARBP2 | Q15633 | 2/20 | 0.74 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.74 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.74 |
| ▸ | PGR | P06401 | 1/20 | 0.74 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.74 |
| ▸ | PDE4A | P27815 | 1/20 | 0.74 |
| ▸ | BLVRB | P30043 | 1/20 | 0.74 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.74 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.74 |
| ▸ | RAB9A | P51151 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | PPID | Q08752 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.43 |
| ▸ | PPARD | Q03181 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15130542 | 0.90 | XDH (0.62) | XDHTARBP2ABCC4ABCB11PGR | |
| SCHEMBL21156694 | 0.90 | XDH (0.75) | XDHTARBP2ABCC4ABCB11PGR | |
| SCHEMBL15131876 | 0.89 | XDH (0.62) | XDHTARBP2ABCC4ABCB11PGR | |
| SCHEMBL2635918 | 0.89 | XDH (0.74) | XDHTARBP2ABCC4ABCB11PGR | |
| SCHEMBL31066924 | 0.89 | XDH (0.74) | XDHTARBP2ABCC4ABCB11PGR | |
| SCHEMBL459923 | 0.88 | XDH (0.58) | XDHTARBP2ABCC4ABCB11PGR | |
| SCHEMBL20590214 | 0.88 | XDH (0.64) | XDHTARBP2ABCC4ABCB11PGR | |
| SCHEMBL8867538 | 0.88 | XDH (0.72) | XDHTARBP2ABCC4ABCB11PGR | |
| SCHEMBL8867461 | 0.88 | XDH (0.72) | XDHTARBP2ABCC4ABCB11PGR | |
| SCHEMBL878644 | 0.88 | XDH (0.72) | XDHTARBP2ABCC4ABCB11PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150141658-A1 | PREPARATION OF FEBUXOSTAT | REDDYS LAB LTD DR (IN) | 2015-05-21 | — | — | US | disclosed |
| US-20150141658-A1 | PREPARATION OF FEBUXOSTAT | REDDYS LAB LTD DR (IN) | 2015-05-21 | — | — | US | disclosed |
| US-8969582-B2 | Preparation of febuxostat | DR. REDDY'S LABORATORIES LTD. (IN) | 2015-03-03 | — | — | US | disclosed |
| US-8969582-B2 | Preparation of febuxostat | DR. REDDY'S LABORATORIES LTD. (IN) | 2015-03-03 | — | — | US | disclosed |
| US-20140051733-A1 | FEBUXOSTAT PHARMACEUTICAL COMPOSITIONS | DR. REDDY'S LABORATORIES LTD. (IN) | 2014-02-20 | — | — | US | disclosed |
| US-20140051733-A1 | FEBUXOSTAT PHARMACEUTICAL COMPOSITIONS | DR. REDDY'S LABORATORIES LTD. (IN) | 2014-02-20 | — | — | US | disclosed |
| US-20130190366-A1 | SUBSTANTIALLY PURE SALTS OF FEBUXOSTAT AND PROCESSES FOR PREPARATION THEREOF | CADILA HEALTHCARE LIMITED (IN) | 2013-07-25 | — | — | US | disclosed |
| US-20130165662-A1 | PREPARATION OF FEBUXOSTAT | DR. REDDY'S LABORATORIES, INC. (US) | 2013-06-27 | — | — | US | disclosed |
| US-20130165662-A1 | PREPARATION OF FEBUXOSTAT | DR. REDDY'S LABORATORIES, INC. (US) | 2013-06-27 | — | — | US | disclosed |
| WO-2011139886-A2 | PREPARATION OF FEBUXOSTAT | DR. REDDY'S LABORATORIES LTD. (IN) | 2011-11-10 | — | — | WO | disclosed |
| WO-2011101867-A2 | SUBSTANTIALLY PURE SALTS OF FEBUXOSTAT AND PROCESSES FOR PREPARATION THEREOF | CADILA HEALTHCARE LIMITED (IN) | 2011-08-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140051733-A1 | FEBUXOSTAT PHARMACEUTICAL COMPOSITIONS | FIP1L1, XDH, FH | XDH 2/4885TARBP2 671/4885ABCC4 480/4885 |
| US-20150141658-A1 | PREPARATION OF FEBUXOSTAT | FIP1L1, FECH, FBP1 | XDH 36/4885TARBP2 2072/4885ABCC4 4462/4885 |
| US-20130190366-A1 | SUBSTANTIALLY PURE SALTS OF FEBUXOSTAT AND PROCESSES FOR PREPARATION THEREOF | KCNMB4, SOD1, KCNN4 | XDH 29/4885TARBP2 2080/4885ABCC4 1074/4885 |
| US-20130165662-A1 | PREPARATION OF FEBUXOSTAT | FIP1L1, FECH, FBP1 | XDH 36/4885TARBP2 2072/4885ABCC4 4462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.